Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease... (Abstract)

Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease – A drug utilization cohort study based on the Norwegian prescription register

Research in Social and Administrative Pharmacy
May–June 2017
https://www.sciencedirect.com/science/article/abs/pii/S1551741117302152

LDN is used increasingly for multiple autoimmune diseases including inflammatory bowel diseases. This study looked a prescriptions dispensed with LDN in 2013 in Norway and concluded there was benefit, but further studies are recommended.